ASRS
SCLN

Arizona State Retirement System’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Arizona State Retirement System’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-27,100
Closed -$304K – 1550
2017
Q3 		$304K Buy
27,100
+100
+0.4% +$1.1K ﹤0.01% 1407
2017
Q2 		$297K Buy
27,000
+200
+0.7% +$2K ﹤0.01% 1390
2017
Q1 		$263K Buy
26,800
+500
+2% +$4.99K ﹤0.01% 1405
2016
Q4 		$284K Buy
26,300
+500
+2% +$5K ﹤0.01% 1389
2016
Q3 		$264K Sell
25,800
-100
-0.4% -$1.09K ﹤0.01% 1380
2016
Q2 		$338K Buy
+25,900
New +$339K ﹤0.01% 1314

Arizona State Retirement System's SCLN Position: Q4 2017 in Review

Arizona State Retirement System sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 27,100 shares — an estimated $304K sold.

Arizona State Retirement System first reported a position in SCLN in Q2 2016 and held it in 6 quarters. The position peaked at $338K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Arizona State Retirement System reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Arizona State Retirement System sold 27,100 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $304K.
  • Arizona State Retirement System first reported a position in Sciclone Pharmaceuticals Inc in Q2 2016 and held it in 6 quarters.
  • Arizona State Retirement System's Sciclone Pharmaceuticals Inc position peaked at $338K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Arizona State Retirement System's 13F filing for Q4 2017, filed 9 Feb 2018.